Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Ben Price acquired 5,000,000 shares of the company’s stock in a transaction on Monday, March 31st. The shares were purchased at an average cost of A$0.01 ($0.01) per share, with a total value of A$60,000.00 ($36,363.64).
Percheron Therapeutics Stock Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Featured Articles
- Five stocks we like better than Percheron Therapeutics
- A Deeper Look at Bid-Ask Spreads
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Which Wall Street Analysts are the Most Accurate?
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Investing in Commodities: What Are They? How to Invest in Them
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg&h=45&w=95&zc=2){kind=logo}
